During the past decade, Vancouver Infectious Disease Research and Care Centre conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 5 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Vancouver Infectious Disease Research and Care Centre" #1 sponsor was "Gilead Sciences" with 8 trials, followed by "Vancouver Infectious Diseases Centre" with 2 trials sponsored, "Boehringer Ingelheim" with 1 trials sponsored, "Bristol-Myers Squibb" with 1 trials sponsored and "National Institute of Allergy and Infectious Diseases (NIAID)" with 1 trials sponsored. Other sponsors include -1 different institutions and companies that sponsored additional 9 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Vancouver Infectious Disease Research and Care Centre" #1 collaborator was "Canadian Institutes of Health Research (CIHR)" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Vancouver Infectious Disease Research and Care Centre" are "HIV Infections" (6 trials), "Hepatitis C, Chronic" (3 trials), "Drug Use" (2 trials), "HBV" (2 trials) and "COVID-19" (1 trials). Many other conditions were trialed in "Vancouver Infectious Disease Research and Care Centre" in a lesser frequency.

Most popular intervention types in "Vancouver Infectious Disease Research and Care Centre" are "Drug" (13 trials). Other intervention types were less common.

The name of intervention was led by "TAF" (2 trials), "TAF Placebo" (2 trials), "TDF" (2 trials), "TDF Placebo" (2 trials) and "Allowed third antiretroviral agent" (1 trials). Other intervention names were less common.

The vast majority of trials in "Vancouver Infectious Disease Research and Care Centre" are 16 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Vancouver Infectious Disease Research and Care Centre". undefined are not yet recruiting, 2 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 12 completed trials in Vancouver Infectious Disease Research and Care Centre, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Vancouver Infectious Disease Research and Care Centre, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 7 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".